- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Probiotics on Chemotherapy-induced Diarrhea
Authors
Keywords
-
Journal
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2023-11-01
DOI
10.1080/01635581.2023.2267779
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2023
- (2023) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Phase II, Single-Arm Trial of Sunitinib and Erlotinib in Advanced Renal Cell Carcinoma
- (2022) Zizhen Feng et al. Clinical Genitourinary Cancer
- Association of UGT1A1*6 , UGT1A1*28 , or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis
- (2022) Chalirmporn Atasilp et al. CTS-Clinical and Translational Science
- FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies
- (2022) Carlotta Antoniotti et al. EUROPEAN JOURNAL OF CANCER
- Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancer
- (2022) Martin J. Edelman et al. LUNG CANCER
- Probiotics Improve Postoperative Adaptive Immunity in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
- (2022) Jie Chen et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Rh-Endostatin Plus Irinotecan/Cisplatin as Second-Line Therapy for Advanced Esophageal Squamous Cell Carcinoma: An Open-Label, Phase II Study
- (2022) Zhihuang Hu et al. ONCOLOGIST
- Oral Administration of Probiotics Reduces Chemotherapy-Induced Diarrhea and Oral Mucositis: A Systematic Review and Meta-Analysis
- (2022) Jing Feng et al. Frontiers in Nutrition
- First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors
- (2022) Todd Bauer et al. INVESTIGATIONAL NEW DRUGS
- Safety and efficacy of S-IROX (S-1, irinotecan and oxaliplatin combination therapy) in patients with advanced pancreatic cancer: A multicenter phase 1b dose-escalation and dose-expansion clinical trial
- (2022) Akihiro Ohba et al. EUROPEAN JOURNAL OF CANCER
- A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic in Patients with Functional Diarrhea and High Fecal Calprotectin Levels: A Pilot Study
- (2022) Susie Jung et al. Nutrients
- A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)
- (2022) Masato Ozaka et al. EUROPEAN JOURNAL OF CANCER
- Clostridium butyricum alleviates weaned stress of piglets by improving intestinal immune function and gut microbiota
- (2022) Jianmin Wu et al. FOOD CHEMISTRY
- Adverse reactions and adherence to capecitabine: A prospective study in patients with gastrointestinal cancer
- (2021) Marília B Visacri et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Relation between body composition and severe diarrhea in patients treated with preoperative chemoradiation with capecitabine for rectal cancer: a single-centre cohort study
- (2021) J. M. van Rees et al. BMC GASTROENTEROLOGY
- Nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy
- (2021) Hung-Yuan Yu et al. Journal of the Chinese Medical Association
- Lactobacillus plantarum CCFM1143 Alleviates Chronic Diarrhea via Inflammation Regulation and Gut Microbiota Modulation: A Double-Blind, Randomized, Placebo-Controlled Study
- (2021) Bo Yang et al. Frontiers in Immunology
- Survival effect of probiotics in a rat model of colorectal cancer treated with capecitabine
- (2021) Graciela Gigola et al. World Journal of Gastrointestinal Oncology
- Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)
- (2021) M.M. Javle et al. ESMO Open
- MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
- (2020) Sharon Elad et al. CANCER
- nal‐IRI+5‐FU/LV versus 5‐FU/LV in post‐gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients
- (2020) Makoto Ueno et al. Cancer Medicine
- Probiotics for the Prevention of Antibiotic-associated Diarrhea in Adults
- (2020) Wanqian Liao et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Effects of probiotics on chemotherapy in patients with lung cancer
- (2019) Yang Tian et al. Oncology Letters
- Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer
- (2019) Zuo Fei et al. Gut Pathogens
- A randomized double-blind placebo-controlled trial of probiotics in post-surgical colorectal cancer
- (2019) Liyana Zaharuddin et al. BMC GASTROENTEROLOGY
- Efficacy of different probiotic protocols in irritable bowel syndrome
- (2019) Ding Liang et al. MEDICINE
- Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT
- (2018) Jotham Suez et al. CELL
- Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet
- (2018) Cheng Kong et al. NUTRITION
- Reduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation
- (2017) Ling Ling Chua et al. Microbiome
- A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer
- (2016) M. E. Lacouture et al. ANNALS OF ONCOLOGY
- The Potential Role of Probiotics in Cancer Prevention and Treatment
- (2016) Ai-Qun Yu et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study
- (2015) Michal Mego et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model
- (2015) Chun-Yan Yeung et al. PLoS One
- The efficacy and safety of probiotics in people with cancer: a systematic review
- (2014) M. G. Redman et al. ANNALS OF ONCOLOGY
- Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: A double-blind, randomized, placebo-controlled trial
- (2014) Jee-Yon Lee et al. DIGESTIVE AND LIVER DISEASE
- Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature
- (2014) Sabina Fijan International Journal of Environmental Research and Public Health
- FAO/WHO Guidelines on Probiotics
- (2012) Lorenzo Morelli et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery - a double-blind study
- (2010) Z. Liu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials
- (2010) Kevin Whelan et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Probiotics
- (2010) N. T. Williams AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Faecal microflora and β-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats
- (2010) Andrea M Stringer et al. CANCER BIOLOGY & THERAPY
- Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile
- (2009) Andrea M. Stringer et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Use of Probiotics in the Management of Chemotherapy-Induced Diarrhea: A Case Study
- (2009) Samia Abd El-Atti et al. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
- Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies
- (2009) Mariko Wada et al. SUPPORTIVE CARE IN CANCER
- Review: Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management
- (2009) Alexander Stein et al. Therapeutic Advances in Medical Oncology
- UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma
- (2008) Chun-Yu Liu et al. CANCER
- Evaluation and Management of Treatment-Related Diarrhea in Patients with Advanced Cancer: A Review
- (2008) Nathan I. Cherny JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea
- (2008) Atakan Sezer et al. MEDICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search